Pro-Dex, Inc. (PDEX)
| Market Cap | 115.94M |
| Revenue (ttm) | 36.18M |
| Net Income (ttm) | 6.27M |
| Shares Out | 3.85M |
| EPS (ttm) | 1.55 |
| PE Ratio | 19.34 |
| Forward PE | 20.66 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 19 |
| Last Price | $30.03 |
| Previous Close | $28.70 |
| Change ($) | 1.33 |
| Change (%) | 4.63% |
| Day's Open | 29.10 |
| Day's Range | 29.13 - 30.35 |
| Day's Volume | 20,601 |
| 52-Week Range | 14.04 - 42.60 |
News
Phoenix, Arizona--(Newsfile Corp. - November 11, 2020) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a company that specializes in the design, development, and...
According to the GuruFocus All-in-One Screener, a Premium feature, as of Oct. 8, the following companies are trading below their Peter Lynch fair value with wide margins of safety and have had...
Growth-focused investors may be interested in the following stocks since their price-earnings ratios still trade below 20 and their trailing 12-month earnings per share have grown significantl...
About PDEX
Pro-Dex designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
| Industry Medical Instruments & Supplies | Founded 1978 |
| CEO Richard Van Kirk | Employees 117 |
| Stock Exchange NASDAQ | Ticker Symbol PDEX |
Financial Performance
In 2020, Pro-Dex's revenue was $34.83 million, an increase of 28.20% compared to the previous year's $27.17 million. Earnings were $6.11 million, an increase of 47.35%.
Analyst Forecasts
According to one analyst, the rating for Pro-Dex stock is "Strong Buy" and the 12-month stock price forecast is 40.00.